One Health Biosensing

News

One Drop founder Jeff Dachis brought his new product out of stealth mode at Frontiers Health -- a CGM for use beyond Type 1 diabetes.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.